Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that ...
Precigen, Inc. (Nasdaq: PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients, today announced the ...
New York City Mayor Zohran Mamdani plans to launch a livestream series called “Talk with the People” ...
As education systems evolve, the way exams are designed, conducted, and evaluated is also undergoing a major transformation. In this fireside chat, experts explore the future of smart exam management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results